Introduction
Epilepsy is characterised by neuronal hyperexcitability and hypersynchronicity which manifests as recurrent seizures [1, 2] . The pathophysiological processes underlying epilepsy in its various forms remain incompletely understood (for reviews, see Engelborghs et al. [1] and McCormick and Contreras [2] ) but an imbalance between excitatory and inhibitory neuronal inputs is usually implicated. Critical to understanding the pathophysiology of epileptogenesis and ictogenesis are abnormalities in synaptic transmission, and in particular in the activity of GABAergic synaptic networks [2] [3] [4] [5] . An improved understanding of in vivo synaptic function in epilepsy may inform diagnosis and clinical management.
Within the central nervous system, GABAergic activity can regulate neuronal firing, synchronicity and network oscillations [6] . At a cellular level, activation of post-synaptic GABA receptors results in rapid transient (GABA A R-mediated) and longer-lasting (GABA B R-mediated) inhibitory post-synaptic potentials that can modulate or gate firing of the post-synaptic neuron [7] [8] [9] . Presynaptic GABA B Rs remain active for longer than post-synaptic GABA B Rs, and regulate (reduce) further GABA release by inhibiting Ca 2+ influx, resulting in disinhibition [8, 10, 11] .
In human motor cortex, the activation of GABARs can be measured with TMS using paired-pulse stimulation. SICI occurs when a sub-threshold conditioning pulse is delivered $2 to 6 ms before a supra-threshold test pulse; the conditioning pulse elicits a GABA A R-mediated IPSP and thereby reduces the amplitude of the MEP to the test pulse [12, 13] . The ratio of the amplitude of the conditioned MEP to the MEP for the test pulse alone can be used as an index of GABA A R activation. A supra-threshold conditioning pulse results in activation of post-synaptic GABA B Rs, reducing test MEP amplitudes for conditioned-test ISIs of up to $150 ms (LICI) [14] [15] [16] . Pre-synaptic GABA B Rs activated by the conditioning pulse limit further GABA release, and as they remain active for longer than post-synaptic GABA B Rs a period arises beyond LICI when disinhibition dominates (LCD), and during which MEP amplitude is increased (LICF) and SICI reduced [17] [18] [19] .
As pre-and post-synaptic GABARs can exert widespread influence over neuronal firing, their dysfunction has been implicated in the processes of epileptogenesis and ictogenesis [2, 4, 5, 20] . Previous TMS studies in patients with untreated IGE have reported reduced levels of SICI compared to non-epileptic control subjects [21] [22] [23] [24] [25] , suggesting a state of cortical hyperexcitability with altered (decreased) cortical GABA A activity. Normal levels of SICI have been consistently reported in patients with IGE who are well controlled on AED therapy [21] [22] [23] [24] [25] , apart from those with JME in whom SICI may [23, 26] or may not [27, 28] return to normal levels. The effect of IGE on LICI is not certain.
Although not yet explored in human IGE in vivo, impaired GABA B R-mediated auto-inhibition has been demonstrated in in vitro studies of human brain tissue obtained from patients undergoing surgery for pharmaco-resistant temporal lobe epilepsy [10, 29] . While GABA mediates cortical inhibition and disinhibition in adults, it is known to have excitatory effects early in development [30] . An excitatory role for GABA in epilepsy has also been suggested on the basis of findings in animal models and surgically resected human brain tissue [31] [32] [33] .
In the present study we used TMS to compare the strengths of short-and long-interval intracortical inhibition and disinhibition in the motor cortex in patients with treated and untreated IGE and in controls.
Methods

Subjects
Ten patients diagnosed with IGE (16-37 years of age, mean 23 years; four male, all right hand dominant) were recruited from the Royal Perth Hospital First Seizure Clinic and from a private epilepsy clinic. The diagnosis of IGE was made by an epileptologist (JWD, NDL or PLS) on the basis of clinical assessment and EEG. Patients were divided into two groups according to whether or not they were currently being treated with an AED (not on treatment: AED NO , on treatment: AED ON ). Further patient details are presented in Table 1 . Patients taking multiple AEDs were not recruited. Four patients underwent repeat studies (at least two weeks apart) after commencing (patients #1, #2 and #4) or ceasing (patient #5) AED treatment as part of their prescribed epilepsy management. In total, seven sets of measurements (three unique, four crossover) were obtained from patients off treatment, and seven from patients on AED treatment (three unique, four crossover). Apart from patient #6, all patients were seizure-free for at least 3 months following testing. Twelve healthy individuals (19-32 years of age, mean 23 years; nine male, all right hand dominant) without a history of epilepsy in first-degree relatives were recruited as a control group. Approval for the clinical arm of the study was obtained from the Royal Perth Hospital Human Ethics Committee, and University of Western Australia Human Research Ethics Committee granted approval for control measurements. All participants provided written informed consent according to the Declaration of Helsinki.
Testing was performed at 9 AM, after a minimum of seven hours uninterrupted sleep the night before. Participants abstained from alcohol in the 24 h prior to testing and from stimulant drinks (e.g. coffee, 'energy drinks') on the day of testing. The IGE group were tested at least one week after their last generalised tonic-clonic seizure, and at least 24 h after any other clinical seizure type. No participants were taking medications known to alter seizure threshold (other than a single AED). 
TMS
MEPs were recorded from the right FDI by surface EMG (sample rate 10 kHz, amplification 500Â, filtering 0.02-20 kHz). TMS was delivered through a 7 cm figure-of-eight coil connected to three magnetic stimulators (Magstim 200   2 ; Magstim Co., UK) linked through a custom-built device. The coil was held tangential to the head and positioned in the parasagittal plane at the optimal site for activation of the right FDI (determined from initial exploration over a 1 cm grid). Stimuli were delivered at 0.2 Hz with the FDI relaxed, and peak-peak MEP amplitude was measured. RMT was determined according to the Rossini-Rothwell criterion [34] . As recommended by safety guidelines, in all IGE subjects surface EMG of the right deltoid muscle was monitored so as to detect intracortical spread of excitation [35] , and a neurologist (PLS) was present for all testing. No adverse events occurred during testing.
LICI/LICF
LICI and LICF curves were generated using paired-pulse TMS. The single-pulse TMS intensity needed to evoke a MEP of 1 mV amplitude was first determined (I 1 mV ), and both stimuli in the paired-pulse were set to this intensity. The first pulse in a pair was designated the priming stimulus and the second pulse the test stimulus ( Fig. 1) . Paired-pulses were delivered at 14 ISIs spaced so as to encompass the periods of LICI and LICF (100, 150, 170, 180, 190, 200, 210, 220, 230, 240, 250, 275, 300, 350 ms). ISIs were pseudo-randomised and divided into four blocks, with eight stimuli for each ISI. At each ISI the mean TS-MEP amplitude was calculated as a percentage of the mean PS-MEP. The ISIs corresponding to each subject's greatest LICI and LICF were used in the triple-pulse SICI measurements (SICI LICI and SICI LICF ). In participants with IGE who did not show LICF, the ISI with greatest PS-TS amplitude was used to evaluate SICI LICF .
SICI
Triple-pulse TMS was used to measure SICI during LICI and LICF (Fig. 1) . A supra-threshold PS (at I 1 mV ) was followed by a pairedpulse stimulus designed to elicit SICI, consisting of a sub-threshold conditioning stimulus followed 2 ms later by a supra-threshold test stimulus (TS*) that was intensity-adjusted so as to give a MEP of 1 mV in the presence of LICI or LICF. The CS was delivered at three intensities: 0.7, 0.8 and 0.9 RMT. An ISI of 2 ms was chosen to avoid contamination of SICI by SICF [36] . Unprimed SICI was measured in the absence of a PS, with TS at I 1 mV , and calculated from the ratio (expressed as a percentage) of mean conditioned MEP amplitude (10 stimuli) to mean unconditioned test MEP amplitude (10 stimuli). SICI LICI and SICI LICF were measured in the presence of a PS, and calculated from mean conditioned TS* MEP amplitude to mean unconditioned TS* amplitude (10 stimuli). Stimuli were delivered in blocks of 40 for each of unprimed SICI, SICI LICI and SICI LICF , comprised of 10 conditioned stimuli at each level of RMT and 10 unconditioned stimuli, interspersed pseudo-randomly.
Data analysis
Data was compared between Controls, AED NO and AED ON . All data are expressed as mean AE standard deviation.
LICI/LICF
Mixed model analysis with random individual effects was used to compare responses between groups, and to compare each group's responses to baseline. Data was log transformed where required to better approximate normality for inference purposes. Adjustment for possible differences in baseline values did not alter results.
SICI
Mixed model repeated measures analysis was performed with factors GROUP and RMT for each CONDITION (unprimed SICI, SICI LICI , SICI LICF ). Responses were compared between groups, and within each group responses were compared to baseline for each condition. Adjustment for possible differences in baseline values did not alter results.
Results
LICI and LICF
RMT was similar between groups (p = 0.496). There was no significant difference between baseline MEP amplitudes for Fig. 1 . Protocol diagram. TOP: LICI/LICF curves were generated from paired-pulse TMS, made up of a supra-threshold PS followed by TS (1 mV MEP) delivered 100-350 ms later. This curve was used to identify the timing of strongest LICI (_) and LICF (^) for each individual. BOTTOM: Paired-and triple-pulse TMS was used to measure LICI, LICF, and SICI during both LICI and LICF. LICI/LICF was calculated at each ISI from the amplitude ratio of primed-to-unprimed TS. Unprimed SICI was calculated from the amplitude ratio of unconditioned-to-conditioned TS at ISI 2 ms. At the two post-PS intervals corresponding to LICI and LICF, TS intensity was adjusted to restore MEP amplitude to 1 mV (TS*) in the presence of PS and SICI was then measured by delivering a CS prior to TS*. Controls (1.60 AE 0.30 mV), AED NO (1.19 AE 0.15 mV) and AED ON (1.35 AE 0.09 mV; p = 0.46). Fig. 2A presents the LICI/LICF curves for each group. LICI was of similar magnitude in all groups at ISI 100-150 ms (p = 0.09), with a significant overall reduction in MEP amplitude compared to baseline (mean 46 AE 8% of baseline, p < 0.001). At longer ISIs (200-250 ms) the Control group demonstrated LICF as expected, with MEP amplitude significantly increased compared to baseline (mean 141 AE 17% of baseline, p = 0.015) and peaking at 210 ms (151 AE 21% of baseline). At these longer ISIs there was no statistically significant difference in amplitude compared to baseline for AED NO (107 AE 12%, p = 0.56), while for AED ON the amplitude was reduced, but with marginal significance (79 AE 10% of baseline, p = 0.045). There were significant differences at ISI 200-250 ms when groups were compared: amplitudes in AED ON were lower than both AED NO (p < 0.001) and Controls (p = 0.003), while those for AED NO and Controls were not significantly different to each other (p = 0.2). Stratifying AED ON according to specific AEDs (Fig. 2B) suggests that the difference observed between AED ON and AED NO may be due to lamotrigine. LICI and LICF values for patients tested both on and off AED treatment are listed in Table 2 .
SICI
There was no significant difference in TS*-MEP amplitude between groups (mean 1.20 AE 0.19 mV; p = 0.387), and no difference between MEPs for PS and TS* (p = 0.245). The ISI for SICI LICI was 100 ms in all participants, whereas the ISI for SICI LICF varied between 180 and 250 ms (median 210 ms, interquartile range 203-230 ms). Fig. 3 shows SICI as a function of CS intensity (0.7-0.9 RMT) for each group (Control, AED NO , AED ON ) and each stimulus combination (unprimed SICI, SICI LICI , SICI LICF ). The mean values for unprimed SICI, SICI LICI , SICI LICF in patients tested both on and off AED treatment are listed in Table 2 .
The overall mean unprimed SICI amplitude in the Control group was 29 AE 4% of baseline. Compared to this, SICI was significantly reduced during LICI (68 AE 11% of baseline, p < 0.001), and remained reduced during LICF (53 AE 7% of baseline, p < 0.001). The difference between SICI LICI and SICI LICF was also significant (p = 0.02).
For the AED ON group, SICI LICI (70 AE 10% of baseline) and SICI LICF (55 AE 14% of baseline) were significantly reduced compared to unprimed SICI (37 AE 12% of baseline; p < 0.001 and p = 0.03, respectively). Unprimed SICI and SICI LICI in AED ON were no different to the Control group (p = 0.500 and p = 0.360, respectively).
For the AED NO group, unprimed SICI was reduced compared to AED ON and Controls at CS = 0.8RMT (56 AE 4% of baseline, p = 0.001 and p = 0.004, respectively) and 0.9RMT (52 AE 8% of baseline, p = 0.053 and p = 0.01, respectively). SICI LICI was 120 AE 10% of baseline, indicating that CS increased TS* amplitude (p = 0.017). This was significantly different to the Control (p = 0.007) and AED ON (p = 0.009) groups, in which SICI LICI was less than 100%. During LICF, SICI in the AED NO group was reduced compared to unprimed SICI (72 AE 5% of baseline, p = 0.015). Fig. 4 shows SICI MEP waveforms from a representative participant, demonstrating the expected reduction in conditioned MEP amplitude without PS, but that with PS the conditioned MEP is increased in amplitude relative to the unconditioned MEP.
There was no difference in SICI LICF between any groups (p = 0.980).
Discussion
The present study demonstrates significant differences in cortical inhibition between individuals with IGE and healthy control subjects. Although LICI was unchanged in IGE, there was no evidence for the post-LICI period of facilitation (LICF) that is present in healthy individuals. The strength of SICI was also reduced, and when measured during LICI, the SICI protocol elicited a paradoxical excitatory rather than an inhibitory response in untreated epileptics. Treatment with AEDs was associated with restoration of normal levels of SICI. These findings point to altered function of GABAergic inhibition in epilepsy, and suggest that under some circumstances GABA may have an excitatory rather than an inhibitory action in the cortex in IGE.
The conventional GABA hypothesis of epilepsy suggests that ''a reduction of GABAergic inhibition results in epilepsy while an enhancement of GABAergic inhibition results in an antiepileptic effect'' [37] . In recent years this hypothesis has been challenged by reports of GABA A Rs with excitatory effects, likely due to alterations in chloride homeostasis (for reviews, see [4, [31] [32] [33] [38] [39] [40] ). Activation of the GABA A R opens Cl À channels allowing a flow of ions down their electrochemical gradient. The direction of this gradient is set by the neuronal membrane cotransporters NKCC1 (influx of ions) and KCC2 (efflux of ions) [41] . In utero, relative overexpression of NKCC1 results in high intracellular Cl À concentration, and thus opening of the GABA A R Cl À channel results in a depolarising (outward) ion flow [42] [43] [44] [45] [46] . In normal early human infant life the relative expression of NKCC1 and KCC2 reverses, with over-expression of KCC2, thereby lowering intracellular Cl À concentration such that GABA A R activation induces hyperpolarisation [47, 48] . In vitro studies of adult human brain tissue resected for treatment of pharmaco-resistant TLE demonstrate pathological over-expression of NKCC1 and under-expression of KCC2, in which case activation of GABA A Rs may lead to Cl À efflux and neuronal depolarisation [49] [50] [51] [52] [53] . These same findings have also been reported in epileptogenic peritumoural adult human brain tissue [54] , and in combination with data from animal models suggest a potentially epileptogenic/ictogenic role for GABA A Rs in epilepsy [4, 41] . Recent studies have also identified mutations affecting GABAergic signalling in some individuals with familial IGE, including loss-of-function mutations in Cl À channels resulting in abnormally elevated intracellular Cl À concentration [55] [56] [57] . One possible explanation as to why SICI LICI facilitated MEPs is that LICI may contribute to a reversal of the chloride gradient. During LICI, the GABA B R IPSP (which is mediated by K + outflow [7, 58, 59] ) may reduce KCC2 activity (which depends on the K + gradient to transport Cl À out of the cell) and result in a temporarily higher intracellular Cl À concentration [41, [60] [61] [62] [63] . A sufficiently high concentration could lead to Cl À efflux when GABA A Rs are activated, and therefore a depolarising response to SICI. Collapse of the Cl À gradient with subsequent depolarising responses has been demonstrated in animal models of focal and generalised epilepsy [64] [65] [66] and in adult (focal) epileptic human brain tissue [10, 29] . Changes in K + /Cl À dynamics are thought to contribute to ictal and inter-ictal activity in epilepsy [4, 40, 67] , and may underlie the process of ictogenesis by converting a negative (inhibitory) feedback loop (pyramidal cell activation of inhibitory interneurons) into a positive (excitatory) loop [41, 68, 69] .
In keeping with our previous findings [19] , in healthy individuals LICI at ISIs of 100-150 ms was followed by a period of intracortical facilitation (LICF) between 200 and 250 ms, and disinhibition (detectable as a reduction in SICI) was present throughout both of these periods. This pattern was not observed in IGE, where LICF was absent in both treated and untreated groups of patients, although disinhibition (as determined by SICI LICF ) was present albeit weaker for AED NO . A reduction in the strength (and possibly duration) of pre-synaptic GABA B R activity has been demonstrated in surgically resected brain tissue from adults with focal epilepsy [29] , and this could explain the absence of LICF with weaker SICI LICF in our patients.
Consistent with previous studies in IGE [21] [22] [23] [24] [25] and one study of patients with generalised epilepsy secondary to GABA A R subunit mutation (conferring partial loss of function) [70] , we found a reduction in the strength of unprimed SICI in untreated epilepsy patients compared to healthy controls, and interpret this as evidence of impaired GABA A R function. While this was restored by AED treatment, the number of AEDs in relation to sample size does not enable this restoration of GABA A R function to be interpreted pharmacologically. However, in contrast to Badawy et al. [21] [22] [23] [24] 71, 72] we did not observe LICF in IGE. Badaway et al. found no evidence of LICI in their healthy controls, whereas we found LICI in both controls and IGE, suggesting that there may be an interrelationship between the presence of LICI and LICF [19] . As LICI is a well-established phenomenon in healthy individuals, its absence in the Badaway et al. control groups complicates comparison with the present findings.
The abnormalities in GABA-mediated measurements in the present study warrant further investigation and may have clinical applications for the diagnosis and treatment of IGE. The diagnosis of IGE is primarily clinical based on history and examination, with EEG performed to support the diagnosis and aid in syndromal subclassification and prognostication [73] . However, up to $50% of individuals who present with a seizure will have a normal inter-ictal EEG (which does not exclude the diagnosis of epilepsy) and in others the EEG may be abnormal yet nondiagnostic [74, 75] . In these individuals, if the history is not clearly diagnostic of IGE then measurement of LICF and SICI LICI may be a useful diagnostic adjunct.
In conclusion, we investigated the relationship between presynaptic disinhibition and post-synaptic inhibition in the motor cortex of treated and untreated IGE, and find that, during the period of post-synaptic inhibition, activation of GABA A Rs may have excitatory effects. The findings lend in vivo support to a growing body of evidence from experimental models and in vitro studies of human epileptic brain tissue that GABA may have an excitatory role in epilepsy. Coupled with alterations in disinhibition, the present findings point to a complex modulation of pre-and postsynaptic GABAergic mechanisms in epilepsy.
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